Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Pyxus International Q4 Earnings Call Highlights

Pyxus International (OTCMKTS:PYYX) reported a sharply higher fourth quarter and record full-year adjusted EBITDA for fiscal 2026, with management pointing to strong shipment volumes, disciplined cost control and improved leverage as key outcomes from a year marked by shifting tobacco leaf supply con

Ulta's Q1 Report Primes It for a Beauty of a Rebound

Ulta's Q1 Report Primes It for a Beauty of a Rebound

Ulta is setting up for a robust rebound as growth initiatives gain traction and margins outperform. Analysts forecast a 40% upside and institutions are buying.

Commerzbank CEO Touts AI-Driven 2030 Plan, Calls UniCredit Offer Unattractive

Commerzbank (ETR:CBK) Chief Executive Bettina Orlopp said the German lender’s updated “Momentum 2030” strategy is built on continued revenue growth, lower costs and efficiency gains from artificial intelligence, while reiterating that the bank sees UniCredit’s current takeover offer as unattractive.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Transcontinental Q2 Earnings Call Highlights

Transcontinental (TSE:TCL.A) reported lower second-quarter revenue and slightly lower adjusted profitability from continuing operations, while management said it expects stronger results in the second half of fiscal 2026 following recent contract wins, cost reductions and the national rollout of its

Canaccord Genuity Group Q4 Earnings Call Highlights

Canaccord Genuity Group (TSE:CF) reported a record fiscal 2026 revenue total and sharply higher adjusted profitability, as stronger capital markets activity and continued growth in wealth management helped offset uneven market conditions during the fourth quarter. Chairman and CEO Dan Daviau said t

Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach

Ardelyx (NASDAQ:ARDX) executives said at the Jefferies Global Healthcare Conference that the company is focused on expanding demand for its commercial products, IBSRELA and XPHOZAH, while continuing to invest in its pipeline and positioning the business for sustainable profitability. Chief Financia

Mitie Group H2 Earnings Call Highlights

Mitie Group (LON:MTO) reported double-digit growth in revenue and operating profit for the year ended March 31, 2026, as management said the facilities management company remains on track to deliver its three-year strategic plan through FY 2027. Chief Executive Officer Phil Bentley said the company

inkl

Read news from The Economist, FT, and more,
with one subscription

Apogee Therapeutics Readies Zumi for Phase 3 With Blackstone Backing

Apogee Therapeutics (NASDAQ:APGE) executives said the company is preparing to move its lead drug candidate, zumilokibart, into Phase 3 testing later this year after reporting Phase 2b data in atopic dermatitis and securing a major financing agreement with Blackstone. Speaking at a Jefferies-hosted

CMC Markets H2 Earnings Call Highlights

CMC Markets (LON:CMCX) said it delivered a stronger financial performance in fiscal 2026 as institutional and business-to-business activity continued to scale, while management outlined plans for further investment in retail growth, product expansion and major banking partnerships. Founder and CEO

American Public Education Unveils 2029 Growth Plan Fueled by Military and Nursing Programs

American Public Education (NASDAQ:APEI) outlined a four-year growth plan at a William Blair conference, with Chief Executive Officer Angie Selden saying the company expects revenue and adjusted earnings growth to be driven by its military-focused education business and its nursing education platform

Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout

Annexon (NASDAQ:ANNX) executives outlined a series of expected clinical and regulatory updates across the company’s complement-focused pipeline during a session at the Jefferies Conference, highlighting programs in geographic atrophy, Guillain-Barré syndrome and cold agglutinin disease. Douglas Lov

Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in 2026, supported by a new generic launch, Primatene Mist growth and selected API sales from its China b

ALX Oncology Targets Key Readouts to Advance CD47, EGFR Cancer Drug Programs

ALX Oncology (NASDAQ:ALXO) executives said the company is focused on advancing two clinical-stage oncology programs, with upcoming data readouts expected to shape potential later-stage development plans for its lead CD47 program, evorpacept, and its EGFR-targeted antibody-drug conjugate, ALX2004. S

Autodesk CFO Says MaintainX Deal Extends AI Push Across Asset Lifecycle

Autodesk (NASDAQ:ADSK) Chief Financial Officer Janesh Moorjani said the company’s recent business model changes and planned acquisition of MaintainX are intended to position the design software maker for broader participation across the full asset lifecycle, including operations and artificial intel

Get all your
news in one place.

100's of premium titles.
One news app.

Advanced Energy Industries Sees Semiconductor, Data Center Strength as Margins Climb

Advanced Energy Industries (NASDAQ:AEIS) executives said the company is seeing broad-based strength across its semiconductor, data center and industrial and medical end markets, while also pointing to improving margins and additional manufacturing capacity expected to come online later this year. S

Veeva Systems Q1 Earnings Call Highlights

Veeva Systems (NYSE:VEEV) reported a strong start to the year, with Chief Executive Officer and Co-Founder Peter Gassner saying the company delivered results ahead of guidance as it expands its focus on artificial intelligence for the life sciences industry. On the earnings call, Gassner said total

IDT Q3 Earnings Call Highlights

IDT (NYSE:IDT) raised its full-year fiscal 2026 profit outlook after reporting higher third-quarter revenue, record gross profit and expanding margins, driven by growth in its higher-margin NRS, Fintech and net2phone segments. Chief Executive Officer Shmuel Jonas said the company’s year-over-year r

Netskope Q1 Earnings Call Highlights

Netskope (NASDAQ:NTSK) reported first-quarter fiscal 2027 revenue above its guidance and raised its full-year revenue outlook, as executives said demand remains healthy for the company’s cloud security, networking and emerging AI security products. Chief Executive Officer and Co-Founder Sanjay Beri

Get all your
news in one place.

100's of premium titles.
One news app.

The Descartes Systems Group Q1 Earnings Call Highlights

The Descartes Systems Group (NASDAQ:DSGX) reported record quarterly results for the first quarter of fiscal 2027, with management pointing to growth in global trade intelligence, e-commerce customs entries, fleet performance management and transportation visibility despite a challenging freight mark

Broadcom Q2 Earnings Call Highlights

Broadcom (NASDAQ:AVGO) reported record fiscal second-quarter 2026 revenue and issued a sharply higher outlook for the current quarter, as President and CEO Hock Tan said demand for the company’s artificial intelligence semiconductors remains “simply insatiable.” On the earnings call, Tan said total

Tilly's Q1 Earnings Call Highlights

Tilly's (NYSE:TLYS) reported a sharply narrower first-quarter loss and continued comparable sales growth, as management said the retailer’s turnaround efforts are showing more consistent results across stores and e-commerce. On the company’s fiscal 2026 first-quarter earnings call, President and Ch

C3.ai Q4 Earnings Call Highlights

C3.ai (NYSE:AI) reported fiscal fourth-quarter revenue of $51.6 million and outlined an accelerated restructuring plan that founder, Chairman and Chief Executive Officer Tom Siebel described as a companywide turnaround effort aimed at restoring revenue growth, cash generation and non-GAAP profitabil

Petco Health and Wellness Q1 Earnings Call Highlights

Petco Health and Wellness (NASDAQ:WOOF) reported a return to positive comparable sales in the first quarter of fiscal 2026, with management saying early results support the company’s “Reach for the Sky” strategy focused on product improvements, services growth, store experience and omnichannel execu

ChargePoint Q1 Earnings Call Highlights

ChargePoint (NYSE:CHPT) reported first-quarter fiscal 2027 revenue above its guidance range and said it is entering the final year of a three-year strategic plan with renewed emphasis on growth, margin improvement and operating leverage. President and Chief Executive Officer Rick Wilmer said the qu

Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference

Adaptive Biotechnologies (NASDAQ:ADPT) Chief Executive Officer and Co-Founder Chad Robins said the company is focused on expanding its minimal residual disease testing business while pursuing targeted partnerships for its Immune Medicine platform, during a presentation at William Blair’s Growth Stoc

1 … 6 7 8 9

People

Michael Henderson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

National Insurance

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

388,982 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play